Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT02825368
Eligibility Criteria:
Inclusion Criteria:
* Between the ages of 18 and 24 years
* Has received primary childhood DTaP and MMR vaccinations
* Available for a follow up visit (3 weeks after initial visit)
Exclusion Criteria:
* Received a live vaccine in the past 4 weeks
* Has had a serious allergic reaction to a previous vaccination
* Has allergies to one or more of the components of the vaccines to be used (Neomycin, egg protein)
* Has a history of encephalopathy within 7 days of receiving DTP/DTap
* Has received nosodes for Diphtheria, Tetanus, Pertussis, Measles and Mumps
* Has received an adult booster dose of conventional vaccines of diphtheria, pertussis, tetanus, mumps, and measles (Tdap or MMR)
* Has received immunosuppressive doses of steroids or anti-cancer drugs in the past 3 months
* Is pregnant or if there is a chance they could become pregnant during the next month
* Has a moderate to severe acute illness at the time of enrolment
* Has cancer, leukemia, HIV/AIDS, or any other serious immune health condition
* Has a history of Guillaume Barre Syndrome
* Has received blood transfusion, blood products, or immune globulin within the past year
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
24 Years
Study:
NCT02825368
Study Brief:
Protocol Section:
NCT02825368